Search
Displaying results 851 to 860 of 1204.
Clinical development of two antimicrobial agents funded by Else Kröner-Fresenius Foundation
On the way to clinical application, a potential drug must overcome high and cost-intensive hurdles. To enable individual innovative projects that address an important medical need to carry out the legally required clinical trials, the Else Kröner-Fresenius Foundation's…
New research collaboration on next-generation vaccines against gastrointestinal mucosal pathogens
Against this backdrop, the Technical University of Munich (TUM) coordinates the project Vax2Muc (“Next generation vaccines against gastrointestinal mucosal pathogens, using helicobacter pylori as a model pathogen”), an international and interdisciplinary research…
Charles Thom Award 2023 for Rolf Müller
The award ceremony took place during the Annual SIMB Meeting in Minneapolis, recognizing Prof Müller's exceptional contributions to the scientific community. The Charles Thom Award not only recognizes Müller's remarkable achievements but also emphasizes the importance…
Thomas Pietschmann elected to the Executive Board of the DZIF
At the DZIF General Assembly on 8 November 2023, Prof Thomas Pietschmann was unanimously elected as a new member of the five-person DZIF Executive Board . In addition to his roles at three closely linked DZIF member institutions — the HZI in Braunschweig and the MHH and…
Neutralising antibodies that target resistant bacteria
Antibiotic-resistant bacteria pose a growing threat worldwide, not only to infected patients but also to our health systems as a whole. In particular, infections with the bacterium Pseudomonas aeruginosa are feared due to numerous resistance mechanisms and can lead to…
Pathoblockers to the rescue
Your work describes a new treatment option against Pseudomonas aeruginosa . Why is this bacterium so dangerous and why is there a need for new treatment concepts? J. Haupenthal: "This pathogen plays an a major role in infections of the lungs, wounds and eyes and is…
MICROBELIX conquers the Saarland
As part of the citizen science project MICROBELIX, citizens are encouraged to collect soil samples in near-natural areas and send them to researchers at HIPS. There, the microbial composition of the samples is closely examined. The data obtained will subsequently be put…
Project "ChloroMalaria": New class of active ingredients against tropical disease
The infectious disease malaria causes more than 600,000 deaths annually and threatens about half of the global population. As the malaria pathogen Plasmodium falciparum is increasingly developing resistance to the drugs used to treat it, research into new active agents…
Interrogating disease progression and cell processes with TIGER: in vivo and non-invasively
Bacterial and viral infections can cause severe acute symptoms, but they can also have devastating long-term consequences such as triggering cancer. Consequently, scientists are looking for new approaches and technologies to better understand the course of diseases and…
Researchers from Würzburg and the U.S. discover new type of CRISPR gene scissors
Like humans, bacteria and archaea can be attacked by viruses. These microorganisms have developed their own immune defense strategies against their pathogens. Bacterial defenses, such as CRISPR-Cas systems, have diverse proteins and functions that help bacteria protect…
